Cancer cells are characterized by aberrant epigenetic landscapes and often exploit chromatin machinery to activate oncogenic gene expression programs 1 . Recognition of modified histones by 'reader' proteins constitutes a key mechanism underlying these processes; therefore, targeting such pathways holds clinical promise, as exemplified by the development of bromodomain and extra-terminal (BET) inhibitors 2,3 . We recently identified the YEATS domain as an acetyl-lysine-binding module 4 , but its functional importance in human cancer remains unknown. Here we show that the YEATS domain-containing protein ENL, but not its paralogue AF9, is required for disease maintenance in acute myeloid leukaemia. CRISPR-Cas9-mediated depletion of ENL led to anti-leukaemic effects, including increased terminal myeloid differentiation and suppression of leukaemia growth in vitro and in vivo. Biochemical and crystal structural studies and chromatinimmunoprecipitation followed by sequencing analyses revealed that ENL binds to acetylated histone H3, and co-localizes with H3K27ac and H3K9ac on the promoters of actively transcribed genes that are essential for leukaemia. Disrupting the interaction between the YEATS domain and histone acetylation via structurebased mutagenesis reduced the recruitment of RNA polymerase II to ENL-target genes, leading to the suppression of oncogenic gene expression programs. Notably, disrupting the functionality of ENL further sensitized leukaemia cells to BET inhibitors. Together, our data identify ENL as a histone acetylation reader that regulates oncogenic transcriptional programs in acute myeloid leukaemia, and suggest that displacement of ENL from chromatin may be a promising epigenetic therapy, alone or in combination with BET inhibitors, for aggressive leukaemia.
Using a clonal MOLM-13 cell line in which Cas9 expression can be induced by doxycycline (Dox) administration (iCas9-MOLM-13), we observed a consistent effect of ENL sgRNAs on cell growth after Dox treatment (Extended Data Fig. 1e-g) . CRISPR-Cas9-or short hairpin RNA (shRNA)-mediated depletion of ENL also impaired the clonogenic potential of MOLM-13 ( Fig. 1b ) and MV4;11 (Extended Data Fig. 1h , i) cells grown in cytokine-supplemented methylcellulose. ENL depletion increased the surface expression of the myeloid differentiation marker CD11b (also known as ITGAM) ( Fig. 1c ) and induced a morphological change to a macrophage-like appearance (Extended Data Fig. 1j ). Notably, ENL sgRNA-induced growth inhibition and differentiation were rescued by the presence of a mouse Enl (Mllt1) cDNA that contains several mismatches to the human ENL sgRNA ( Fig. 1d and Extended Data Fig. 1k ). In addition to MLLrearranged leukaemias, ENL depletion suppressed the growth of non MLL-rearranged leukaemia cell lines such as U-937 and K562, but not human cervical adenocarcinoma HeLa or osteosarcoma U2OS cells (Extended Data Fig. 1l-o) . ENL silencing also had minimal effect on the growth, colony-forming ability or differentiation potential of sorted Lin − Sca-1 + c-Kit + (LSK) cells that are enriched for haematopoietic stem cells (Extended Data Fig. 1p-r) .
To examine the relevance of ENL and AF9 to leukaemia progression in vivo, MOLM-13 cells were transduced with different sgRNAs and transplanted into immunodeficient recipient mice. The expression of ENL sgRNA resulted in a marked delay in leukaemia progression ( Fig. 1e and Extended Data Fig. 2a ) and prolonged survival of the reci pient mice (Fig. 1f ). Although the terminal leukaemia in the ENL sgRNA group was composed of predominantly sgRNA-positive cells, these leukaemia cells had similar protein levels of ENL to those from the control group (Extended Data Fig. 2b, c) , indicating that the mice succumbed to an outgrowth of cells that escaped ENL depletion. Together, these results suggest a critical requirement of ENL, but not AF9, for AML maintenance in vitro and in vivo.
To identify the transcriptional pathways controlled by ENL, we performed RNA sequencing (RNA-seq) analyses on iCas9-MOLM-13 cells expressing different sgRNAs. Whereas AF9 sgRNA caused minimal changes in gene expression, ENL sgRNA induction led to differential expression of a subset of genes, but not to global transcriptional dysregulation ( Fig. 2a and Extended Data Fig. 3a ). The transcriptional programs altered by the two ENL sgRNAs were highly correlated (Extended Data Fig. 3b ). Gene set enrichment analyses (GSEA) LETTER RESEARCH revealed a marked upregulation of the myeloid lineage differentiation signature along with a downregulation of a leukaemia stem cell and MYC-associated gene expression signature 6 in ENL sgRNA-or shRNA-expressing MOLM-13 and MV4;11 cells ( Fig. 2b and Extended Data Fig. 3c-h ), suggesting that ENL is required to sustain the oncogenic gene expression programs crucial for leukaemia maintenance.
ENL resides in large protein complexes termed the super elongation complex (SEC) 7 , elongation assisting proteins (EAP) 8 or AF4-ENL-P-TEFb complex (AEP) 9 that contain overlapping subunits such as AFF1-AFF4, ELL, EAF1-EAF2, ENL-AF9 and P-TEFb (for simplicity, we refer to SEC hereafter). To determine the genomic distribution of ENL, we generated stable MOLM-13 and MV4;11 cells ectopically expressing Flag-tagged ENL at levels equivalent to the endogenous ENL proteins, and performed chromatin-immunoprecipitation followed by sequencing (ChIP-seq) experiments. ENL bound to a larger cohort of genes than that of MLL-fusion proteins in both cell lines, suggesting a broader role of ENL than MLL-fusion proteins in transcriptional regulation (Extended Data Fig. 4a, b ). There was a greater overlap of ENL-bound genes between the leukaemia cell lines than their overlaps with ENL occupancy in the non-leukaemia HeLa cells (Extended Data Fig. 4c ). Notably, the ENL-bound genes in leukaemia cell lines were significantly enriched in pathways implicated in cancer and haematological disease (Extended Data Fig. 4d ).
ENL ChIP-seq peaks showed a strong enrichment at promoter regions (transcription start site (TSS) ± 3 kb) ( Fig. 2c and Extended Data Fig. 4e ), which overlapped with the promoter-proximal RNA polymerase II (Pol II) peak ( Fig. 2d and Extended Data Fig. 4f ). ENL-bound genes showed a much higher Pol II occupancy than non-ENL-bound genes ( Fig. 2e ). After ENL depletion, Pol II ChIP-seq signals decreased more prominently on ENL-occupied genes than on non-ENL-bound genes (P < 0.0001), including two key AML transcription factors MYC and H2.0-like homeobox (HLX) 10 ( Fig. 2e and Extended Data Fig. 4g , h). The reduction of Pol II occupancy spanned from the promoter proximal region to the 3′ end of gene body, suggesting reduced Pol II activities in both transcriptional initiation and elongation. Indeed, ChIP-seq analyses of the elongation-specific Pol II that is phosphorylated at serine 2 (S2P) 11 showed a markedly decreased occupancy of the elongating Pol II on ENL target genes in ENL-depleted cells ( Fig. 2f and Extended Data Fig. 4i ). In addition, ENL depletion also resulted in a decrease in the occupancy of CDK9, a SEC component 12 that phosphorylates Pol II at the serine 2 site 13 , and the DOT1L-mediated H3K79me2 and H3K79me3 on ENL-target genes ( Fig. 2g and Extended Data Fig. 4j , k). Together, these data suggest that ENL regulates gene expression by modulating the recruitment of Pol II through both the SEC and DOT1L complexes.
In light of the AF9 YEATS domain being a reader for histone acetylation 4 , we proposed that ENL might link the Pol II transcriptional machinery to chromatin through its YEATS domain. To test this hypothesis, we performed histone peptide array screening and found that the ENL YEATS domain bound specifically to a subset of acetylated histone H3 peptides (Extended Data Fig. 5a ). Preferential binding to the H3K27ac, H3K9ac and H3K18ac peptides was further confirmed by peptide pulldown ( Fig. 3a ) and quantitative isothermal titration calorimetry (ITC) assays ( Fig. 3b) , with binding dissociation constants (K d ) of 30.5, 32.2 and 50.0 μM for H3K27ac, H3K9ac and H3K18ac, respectively. To explore the underlying molecular basis of this binding specificity, we 4  8  12  16  0   30   60   90   120   4  8  12  16   0   25   50   75   100   4 8 12 16 20 24  0   20   40   60   80   100   120   140   ENL-sg1  ENL-sg5  AF9-sg1  AF9- 
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solved the co-crystal structure of human ENL YEATS bound to the H3K27ac peptide at 2.7 Å (Extended Data Table 1 ). The ENL YEATS domain adopts an eight-stranded β-sandwich fold ( Fig. 3c ) with the H3K27ac peptide snugly attached to an acidic surface at the top ( Fig. 3d ) and the flat acetylamide group of K27ac sandwiched by aromatic residues F59 and Y78 ( Fig. 3e ). Recognition of the H3K27ac peptide is further stabilized by a network of hydrogen bonds in addition to hydrophobic contacts (Extended Data Fig. 5b ). Acetylated histone H3 at K9, K18 and K27 share a common 'R-Kac' recognition signature, in which the '−1' arginine forms a charge-stabilized hydrogen bond with D103 of ENL ( Fig. 3e ). Structure-based mutagenesis followed by isothermal titration calorimetry (ITC) and peptide pull-down assays revealed a 2.3-fold to more than 17-fold affinity drop or binding elimination upon alanine mutation of the R-Kac-binding residues ( Fig. 3f, g) . ChIP-seq analyses of both MOLM-13 and MV4;11 cells revealed that ENL-bound peaks were associated with regions of H3K9ac or H3K27ac modifications ( Fig. 3h and Extended Data Fig. 6a ). Consistently, the 
sgRNA: Supplementary Table 3 Y78 LETTER RESEARCH average distribution of ENL correlated extremely well with that of H3K9ac and H3K27ac in the region immediately downstream of the TSS ( Fig. 3i and Extended Data Fig. 6b, c) . Notably, compared to wildtype ENL, the YEATS domain mutants deficient in acetyl-binding exhibited markedly reduced occupancy at ENL-bound genes ( Fig. 3j and Extended Data Fig. 6d-f ), whereas their interactions with other SEC components were not affected (Extended Data Fig. 6g, h) . The ENL YEATS domain is also required for Pol II recruitment, as cells expressing the YEATS mutants exhibited reduced Pol II occupancy on ENL target genes such as MYC (Extended Data Fig. 6i ). Together, these findings revealed an important 'reader' function of the YEATS domain in mediating the chromatin localization of ENL and the recruitment of the Pol II transcriptional machinery.
To test whether the YEATS domain is required for ENL-dependent maintenance of oncogenic gene expression in leukaemia, we performed rescue experiments with ectopically expressed mouse wildtype or mutant ENL proteins in cells expressing a human ENL sgRNA. Transcriptional profiling analyses revealed that wild-type ENL, but not the F59A or Y78A mutant, restored the transcriptional changes caused by the ENL sgRNA (Fig. 4a ). GSEA analyses further demonstrated the incompetency of these ENL mutants to revert the effect of ENL depletion on the expression of genes involved in crucial cellular processes ( Fig. 4b and Extended Data Fig. 7a ). Consequently, the mutants were unable to rescue the growth and differentiation defects caused by ENL inhibition (Fig. 4c, d and Extended Data Fig. 7b ). In line with these observations, replacement of the ENL YEATS domain with that of AF9 retained the full functionality of ENL (Extended Data Fig. 7c, d) . Finally, mice transplanted with ENL sgRNA-transduced cells expressing mutant ENL proteins exhibited a marked decrease in leukaemia burden and prolonged survival as compared to the wild-type counterpart ( Fig. 4e and Extended Data Fig. 7e ). Taken together, these findings demonstrate a crucial role for the ENL YEATS-histone acetylation interaction in regulating oncogenic gene expression and leukaemia maintenance.
Strategies to disrupt the interaction between acetylated histones and their reader proteins, such as the BET family of bromodomain-containing proteins, have been shown to be effective in clinical trials for treatment of a variety of cancers, including haematological malignancies 14 . Interestingly, similar to ENL, BRD4 also associates with P-TEFb and modulates the Pol II transcriptional machinery to regulate key oncogenes such as MYC 15 . This finding raised the possibility that ENL and BRD4 might cooperate to sustain optimal oncogenic gene expression programs crucial for leukaemias. In line with this speculation, depletion Fig. 7b for quantification. n = 3. e, Kaplan-Meier survival curves of mice (n = 10 per group) transplanted with MOLM-13 cells transduced with indicated sgRNAs and rescue constructs. P < 0.0001 using a log-rank test. f, Effect of JQ1 on the proliferation (normalized to DMSO control) of MOLM-13 cells transduced with indicated sgRNAs and rescue constructs. n = 5. g, h, Leukaemia burden (g) and survival curves (h) of mice transplanted with iCas9-MOLM-13 cells expressing indicated sgRNAs. Treatment with JQ1 (or vehicle control) and doxycycline was initiated at day 10 after transplantation. g, Percentage of human CD45 + cells in the peripheral blood of mice (n = 5) at 40 days after transplantation. P < 0.01 (ENL sgRNA plus JQ1 versus all other groups) using Mann-Whitney test. h, Kaplan-Meier survival curves of JQ1-treated mice and vehicle controls (n = 10 per group). P < 0.0001 (ENL sgRNA plus JQ1 versus all other groups) using a log-rank test. i, j, RNA for RNA-seq experiments was obtained from sorted RFP + sgRNA + iCas9-MOLM-13 cells treated with DMSO or 50 nM JQ1 for 24 h. Genes found to be more than twofold downregulated (i) or upregulated (j) after JQ1 treatment in ENL sgRNA-expressing cells were examined. Left, box plots comparing the JQ1-induced fold changes of these genes in either control (red) or ENL sgRNA-expressing (blue) cells. Error bars indicate minimum and maximum, lines denote median, and top and bottom of boxes denote first and third quartile, respectively. P = 2.29 × 10 −7 (i) and P = 2.44 × 10 −7 (j) by two-tailed paired Student's t-test. Right, pie charts showing the categorization of these genes based on the relationship to ENL depletion. Genes in which the absolute JQ1-induced fold change was more than 1.2-fold higher or lower in ENL sgRNA-expressing cells compared to control were classified as enhanced (blue) or decreased (green) by ENL sgRNA, respectively. There are significantly more genes in the enhanced than the decreased by ENL sgRNA group (P < 0.0001 by Fisher's exact test). See Supplementary Table 10 . All error bars represent mean ± s.d. (n = 3) unless noted otherwise.
of ENL or other SEC components sensitized MOLM-13 cells to the BET bromodomain inhibitor JQ1 (ref. 2; Fig. 4f and Extended Data Fig. 8a) . Point mutations disrupting the interaction between the ENL YEATS domain and histone acetylation were sufficient to confer cells with greater sensitivity to JQ1 (Fig. 4f ). Increased JQ1 sensitivity by ENL silencing was also observed in a panel of leukaemia cell lines, but not in HeLa or U2OS cells (Extended Data Fig. 8b-d ). Furthermore, ENL depletion coupled with JQ1 treatment resulted in a significant survival advantage compared with single treatments in vivo (Fig. 4g, h and Extended Data Fig. 8e ). Mechanistically, ENL depletion markedly enhanced JQ1-induced transcriptional changes in MOLM-13 cells, including MYC (Fig. 4i, j and Extended Data Fig. 8f-i) , the inhibition of which has been shown to contribute to the sensitivity to BET inhibitors 16, 17 . Together, these findings suggest that inhibition of ENL functionality is a potential therapeutic strategy to synergize with BET inhibitors.
Cancer cells often co-opt chromatin regulatory pathways and the general transcriptional machinery to sustain the oncogenic state; hence chromatin and transcriptional regulators are being explored as promising candidate drug targets. Targeting epigenetic readers represents a class of anti-cancer therapy that holds clinical promise. Our study reveals ENL as a chromatin reader that regulates oncogenic programs by linking histone acetylation and the transcription apparatus in AML, thus establishing the ENL YEATS domain as a potential drug target, either alone or in combination with BET inhibitors. Notably, recurrent mutations in the ENL YEATS domain were recently reported in Wilms' tumours 18 , suggesting potentially crucial and broad roles of the 'reader' function of ENL in other cancer types that warrant future investigations.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Plasmids. Mouse wild-type or mutant Enl were cloned into pMSCV-IRES-GFP. Human ENL, DOT1L, AFF4, ELL2 and CDK9 cDNA in pENTR or pDONR were purchased from Open Biosystems. The coding sequences in pENTR were subsequently cloned into p3FLAG, pCDH-Flag, or pCAG-Myc destination vectors using Gateway techniques (Invitrogen). Constitutive (pLKO5d.EFS.SpCas9.P2A.BSD, Addgene 57821, a gift from B. Ebert) and inducible (pCW-CAS9, Addgene 50661, a gift from E. Lander and D. Sabatini) Cas9 vectors were used to generate Cas9expressing cells. All shRNAs targeting human and mouse ENL were obtained from Sigma. sgRNAs were cloned into pLKO5.sgRNA.EFS.tRFP657 vector (Addgene 57824, a gift from B. Ebert). All shRNA and sgRNA sequences used are provided in Supplementary Table 11 . Cell culture, virus transduction and functional assays. Human leukaemia cell lines MOLM-13, MV4;11, ML-2, SEMK2, U-937 and K562 were maintained in RPMI 10% FBS supplemented with 2 mM l-glutamine and 100 U ml −1 penicillin/ streptomycin. HeLa and U2OS cell lines were maintained in DMEM 10% FBS supplemented with 2 mM l-glutamine and 100 U ml −1 penicillin/streptomycin. Lin − Sca-1 + c-Kit + (LSK) cells were freshly sorted from the bone marrow of 6-8-week-old C57BL/6J male mice and cultured in IMDM plus 15% FBS supplemented with 20 ng ml −1 mouse SCF (PeproTech), 10 ng ml −1 mouse IL-3 (PeproTech) and 10 ng ml −1 mouse IL-6 (PeproTech). All cell culture medium contained l-glutamine (2 mM; Gibco), penicillin (100 U ml −1 ; Gibco), streptomycin (100 μg ml −1 ; Gibco) and plasmocin (5 μg ml −1 ; InvivoGen). All human cell lines were mycoplasma-negative and were tested for authentication by short tandem repeat (STR) profiling performed by ATCC or by the MDACC CCSGfunded Characterized Cell Line Core, NCI CA016672.
Lentivirus and retrovirus packaging were performed in HEK293T and Platinum-E cells (Cell Biolabs), respectively, using Lipofectamine 2000 reagent (Invitrogen) in accordance with the manufacturer's instructions. Medium containing virus was concentrated using PEG-it Virus Precipitation Solution (System Biosciences). Spin infection was performed at 1,500 rcf at 35 °C for 90 min and transduced cell populations were usually selected or sorted 48 h after infection.
Competitive proliferation assays using sgRNAs: for constitutive Cas9 expression, cells were analysed for RFP + expression 3 days after infection. For Dox-regulated Cas9 expression cells, cells were analysed for RFP + expression before and after Dox treatment (1 μg ml −1 ). The percentage of sgRNA-expressing cells (RFP + ) was measured over time using flow cytometry and normalized to the starting time point.
Colony-forming assays were performed in Methocult (StemCell Technologies, no. H4435 for human leukaemia cells and M3234 supplemented with 20 ng ml −1 mouse SCF, 10 ng ml −1 mouse IL-3 and 10 ng ml −1 mouse IL-6 for mouse LSKs). Indicated number of cells was resuspended in 100 μl PBS and added to 900 μl Methocult. After 7 days, different types of colony were counted. Cell viability assays for JQ1 treatment were performed using CellTiter-Glo Luminescent Cell Viability Assay (promega/VWR) according to manufacturer's guidelines.
For flow cytometry immunophenotyping, cultured or freshly dissociated cells were collected and stained using the indicated antibodies. Stained samples were analysed on an LSR Fortessa (BD) flow cytometer. Data analysis was performed using FlowJo software. Antibodies. All antibodies used are provided in Supplementary Table 12 . qRT-PCR analyses. Total RNA was isolated using the RNeasy kit (Qiagen) and reverse transcribed with the high capacity cDNA reverse transcription kit (Applied Biosystems) in accordance with the manufacturer's instructions. Quantitative PCR was performed using the SYBR Green PCR Master Mix (Applied Biosystems) with the StepOne System (Applied Biosystems). qPCR primers used are provided in Supplementary Table 11 . RNA sequencing. RNA was isolated from human leukaemia cells using the RNeasy Mini Kit (Qiagen) and then samples were prepared as instructed using the TruSeq RNA Sample Preparation Kit v2 (Illumina) in accordance with the manufacturer's instructions. RNA-seq samples were sequenced using Illumina NextSeq 500. Raw reads were mapped to human reference genome (hg19) and transcriptome using the TopHat2 package 19 . Transcript abundances were quanti fied using htseq-count v0. 6.0 (ref. 20) . Differentially expressed genes were determined using DESeq2 (ref. 21) Genes with a fold change of 1.5 were selected as differential genes. Gene Ontology analysis used the Panther 22 Classification System (http://www.pantherdb.org). GSEA. GSEA 23 was performed using GSEA v2.2.2 software with 1,000 gene set permutations. Gene sets used were obtained from the Molecular Signatures Database v4.0 (MSigDB, http://www.broadinstitute.org/gsea/msigdb/index.jsp, C2 curated gene sets or C6 oncogenic signatures) or were manually curated from published data set. A detailed description of GSEA methodology and interpretation can be found at http://www.broadinstitute.org/gsea/doc/GSEAUserGuideFrame. html. Normalized RNA-seq data were rank-ordered by expression fold change.
Enrichment cores are defined as the members of the gene set that lie before or at the running sum peak (that is, the enrichment score) of the ranked gene list. The normalized enrichment score (NES) provides the degree to which a gene set is overrepresented at the top or bottom of a ranked list of genes. The nominal P value describes the statistical significance of the enrichment score. The FDR q value is the estimated probability that a gene set with a given NES represents a false positive finding. All gene sets used in this study are provided in Supplementary Table 13 . ChIP and ChIP-seq analysis. ChIP analysis was performed essentially as described previously 4 . In brief, cells were cross-linked with 1% formaldehyde for 10 min and stopped with 125 mM glycine. The isolated nuclei were resuspended in nuclei lysis buffer and sonicated using a Bioruptor Sonicator (Diagenode). The samples were immunoprecipitated with 2-4 μg of the appropriate antibodies overnight at 4 °C. Protein A/G beads (Millipore) were added and incubated for 15 min, and the immunoprecipitates were washed twice, each with low-salt, high-salt and LiCl buffer. Eluted DNA was reverse-crosslinked, purified using PCR purification kit (Qiagen), and analysed by quantitative real-time PCR on the ABI 7500-FAST System using the Power SYBR Green PCR Master Mix (Applied Biosystems).
ChIP-seq samples were sequenced using the Illumina Solexa Hiseq 2000 or NextSeq 500. The raw reads were mapped to human reference genome NCBI 36 (hg19) by Solexa data processing pipeline, allowing up to two mismatches. The genome ChIP-seq profiles were generated using MACS 1.3.6 with only unique mapped reads 24 . Clonal reads were automatically removed by MACS. The ChIPseq profiles were normalized to 20,000,000 total tag numbers, and peaks were called at P ≤ 1 × 10 −8 . Peaks within 1 kb neighbourhood were merged together across multiple samples in the peak overlap analysis. Peptide microarray and peptide pull-down assay. Peptide microarray and peptide pull-down assays were performed as described previously 25 . In brief, biotinylated histone peptides were printed in triplicate onto a streptavidin-coated slide (PolyAn) using a VersArray Compact Microarrayer (Bio-Rad). After a short blocking with biotin (Sigma), the slides were incubated with the glutathione S-transferase (GST)tagged ENL YEATS domain in binding buffer (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.1% NP-40, 1 mM PMSF, 20% FBS) overnight at 4 °C with gentle agitation. After being washed with the same buffer, the slides were probed with an anti-GST primary antibody and then a fluorescein-conjugated secondary antibody and visualized using a GenePix 4000 scanner (Molecular Devices). For the peptide pull-down assays, 1 μg of biotinylated histone peptides with different modifications were incubated with 1-2 μg of GST-fused proteins in binding buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 0.1% NP-40, 1 mM PMSF) overnight. Streptavidin beads (Amersham) were added to the mixture, and the mixture was incubated for 1 h with rotation. The beads were then washed three times and analysed using SDS-PAGE and western blotting. Co-immunoprecipitation. Co-immunoprecipitation was performed essentially as described previously 4 . Cells were lysed in cell lysis buffer containing 50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 0.5% Triton X-100, 10% glycerol, 1 mM DTT, and a complete protease inhibitor tablet (Roche). Antibodies conjugated with protein A/G beads (Millipore) or anti-Flag M2-conjugated agarose beads (Sigma) were incubated with the lysates overnight at 4 °C. The beads were then washed 3-6 times with cell lysis buffer, and the bound proteins were eluted in SDS buffer and analysed by western blotting. Crystallographic studies. ENL YEATS domain (1-148) and the mutants were recombinantly expressed in E. coli and purified as N-terminally His-Sumotagged proteins. After Ni column chromatography followed by ulp1 digestion for tag removal, ENL proteins were further purified via ion exchange and sizeexclusion chromatography. Before crystallization, ENL sample was mixed with H3(15-39)K27ac peptide in 1:2 molar ratio for about 30 min. Crystallization was performed under 4 °C via vapour diffusion method under the condition: 0.2 M K/Na tartrate, 0.1 M sodium citrate tribasic dihydrate, pH 5.6 and 2 M ammonium sulfate. Diffraction data were collected at Shanghai Synchrotron Radiation Facility BL17U under cryo-conditions. All structures were determined by molecular replacement and refined by the program PHENIX with iterative model building by the program COOT. Detailed data collection and refinement statistics are summarized in Extended Data Table 1 . ITC titration. All ITC titrations were performed under 15 °C using a MicroCal iTC200 instrument. The titration curves were fitted according to the 'one set of sites' binding model. A high-salt titration buffer (500 mM NaCl, 25 mM Tris-HCl, pH 7.5, 2 mM β-mercaptoethanol) was used for ENL YEATS in order to avoid protein aggregation. Animal experiments. All the mouse experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute (DFCI). Leukaemia cells (iCas9-MOLM-13) were transplanted by tail-vein injection of 1 × 10 6 cells into sub-lethally (2 Gy) irradiated female NSG recipient mice at the age of 6-8 in the Gene Expression Omnibus (GEO) database under accession numbers GSE80779 and GSE80774, respectively. All other raw data generated or analysed during this study are included in this published article (and its Supplementary Information files). weeks (n = 10 per group). Dox-containing chow and water were supplied during the course of the experiments. For JQ1 ex vivo treatment trials, leukaemia cells were treated with 1 μg ml −1 doxycycline for 2 days and then treated with 100 nM JQ1 and 1 μg ml −1 doxycycline for the next 2 days before equal number of viable cells were transplanted. For JQ1 in vivo treatment trials, JQ1 was resuspended in DMSO at 200 mg ml −1 (for 50 mg kg −1 dosing) and then diluted 1:20 with 10.5% (2-hydroxypropyl)-β-cyclodextrin in 0.9% sterile saline. The solution was sonicated until homogenous. Vehicle was prepared and administered the same with the exception that no JQ1 was added. 100 μl doses were administered by intraperitoneal injection for 5 consecutive days with 2-day rest for 30 days starting from day 10 after transplantation. The animals were randomly assigned to the experimental groups. Kaplan-Meier survival curves of mice and the log-rank test were performed using the Prism 6 software program (GraphPad). No animal was excluded from any of the analyses. The investigators were not blinded to allocation during experiments and outcome assessment. Statistical analyses. Experimental data are presented as mean ± s.e.m. unless stated otherwise. Statistical significance was calculated by two-tailed unpaired t-test on two experimental conditions with P < 0.05 considered statistically significant unless stated otherwise. Statistical significance levels are denoted as follows: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. No statistical methods were used to predetermine sample size. and key residues of ENL YEATS (blue) are depicted in ball-and-stick mode. Grey ball, carbon; blue ball, nitrogen; red ball, oxygen; large cyan sphere, water molecule. Hydrogen bonds are indicated as green dashed lines with bond length shown in ångströms. Hydrophobic contacts are represented by an arc with spokes radiating towards the ligand atoms they contact, and the contacted atoms are shown with spokes radiating back.
